Article

Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 Infection

2020-03-22

Abstract excerpt

Drug repositioning offers an unmatched opportunity to offer novel therapeutics to treat SARS family of coronaviruses (SARS-FCoVs); an issue that became extremely urgent with the spreading of a novel virus with potential to threaten the lives of millions of people. Hereby, we analyzed a dataset of patients who presented with SARS during the 2003 outbreak. We established a gene signature that defines differential ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7f28e205-d0a9-505d-8052-187361bccd46
DOI: 10.21203/rs.3.rs-18714/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 InfectionDOI 10.21203/rs.3.rs-18714/v1Read

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19Semantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analysesSemantic proximity Read

Focusing on the Unfolded Protein Response and Autophagy Related Pathways to Reposition Common Approved Drugs against COVID-19Semantic proximity Read

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSemantic proximity Read

Ontological and Bioinformatic Analysis of Anti-Coronavirus Drugs and Their Implication for Drug Repurposing against COVID-19Semantic proximity Read

Computational Approaches to Assist Drug Repositioning for COVID-19Semantic proximity Read

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Semantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Drug repositioning in response to COVID-19 and other challenging diseasesSemantic proximity Read